Hinge Health Projects Q2 Revenue of $200M-$202M
Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Health Tech Stocks · Healthcare
Sentiment
Neutral
Importance
8
Price
$64.74
Mkt Cap
$4.858B
52W Low
$30.08
52W High
$66.55
52W Position
115% above low
Off High
2.7% below high
Rel. Volume
1.3× avg
Market data snapshot near publication time
HNGE has more than doubled off its 52-week low of $30.08.
Summary
Hinge Health projects Q2 revenue to be between $200 million and $202 million. This guidance follows the company's strong Q1 2026 results reported on May 5th, which saw revenue of $182.31 million and a raised full-year outlook. The projected sequential growth from Q1 to Q2 is a key indicator for traders assessing the company's ongoing performance and momentum.
At the time of this announcement, HNGE was trading at $64.74 on NYSE in the Technology sector, with a market capitalization of approximately $4.9B. The 52-week trading range was $30.08 to $66.55. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
HNGE - Latest Insights
HNGE
Jul 07, 2026, 5:48 PM EDT
Price at Filing:
$88.80
Real-time Price:
$76.58
Change:
-$12.22 (-14%)
Market Cap:
$5.823B
HNGE
Jul 07, 2026, 4:46 PM EDT
Price at Filing:
$89.30
Real-time Price:
$76.58
Change:
-$12.72 (-14%)
Market Cap:
$5.823B
HNGE
Jul 07, 2026, 4:37 PM EDT
Price at Filing:
$89.30
Real-time Price:
$76.58
Change:
-$12.72 (-14%)
Market Cap:
$5.823B
HNGE
Jul 07, 2026, 4:27 PM EDT
Price at Filing:
$89.30
Real-time Price:
$76.58
Change:
-$12.72 (-14%)
Market Cap:
$5.823B
HNGE
Jul 07, 2026, 4:14 PM EDT
Price at Filing:
$89.30
Real-time Price:
$76.58
Change:
-$12.72 (-14%)
Market Cap:
$5.823B